Dissertation > Excellent graduate degree dissertation topics show

Inhibition of DHA on Fe2+-dependent Growth of Cervical Cancer Cells and Anti-cancer Effect in DHA Combination with CDDP

Author: TangLin
Tutor: ZhangGuoZuo
School: Chengdu University of Traditional Chinese Medicine
Course: Chinese Gynecology
Keywords: dihydroartemisinin cisplatin Cervical cancer cells growthinhibition pro-apoptosis
CLC: R737.33
Type: Master's thesis
Year: 2013
Downloads: 3
Quote: 0
Read: Download Dissertation


Objective Study the mechanism of Dihydroartemisin innhibit Hela cells growth and promote its apoptosis. Research on dihydroartemisinin Whether to inhibit Hela cell growth and promote its apoptosis.Methods This study using MTT chromatometry to test:(1) inhibition of Hela cells growth of dihydroartemisinin and cisplatin by different concentrations;(2) whether to Increase sensitivity combining dihydroartemisinin (ICio) with cisplatin;(3) whether have synergistic action dihydroartemisinin (IC20-IC50) combining cisplatin (IC20-IC50). Deferoxamine treatment to the Hela cell6hours later, different concentrations of dihydroartemisinin and dihydroartemisinin (IC50) were added;(4) the proliferation and inhibition of Hela cell.Appling cell cloning method to test the growth inhibition of dihydroartemisinin (IC20-IC50) and cisplatin (IC20-IC50) single and combination to treat the Hela cell. Using flow cytometry to test apoptosis rate of Hela cee after treat by single dihydroartemisinin (IC20-IC50)and cisplatin (IC20-IC50) or combination.Results (1) High concentration of dihydroartemisinin and cisplatin will inhibit the proliferation of Hela cell.(2)Combination of dihydroartemisinin IC10and cisplatin72hours later, there is no effect of inhibit the proliferation of Hela cell. dihydroartemisinin couldn’t enhance the effection of cisplatin (P>0.05).(3) The results of MTT colorimetric method show that there is no synergistic action of dihydroartemisinin (IC20-IC50) combing cisplatin (IC20-IC50)72hours later (P>0.05).(4)Deferoxamine treatment(0μmol/L、25μmol/L、100μmol/L、200μmol/L) to the Hela cell6hours later, the function of inhibit proliferation was depressed, Deferoxamine0μmol/L、25μmol/L、100μmol/L、200μmol/L act on the Hela cell78hours later, the survival rate of cells was decline along with the concentration reduction.(5) After pretreatment of Hela cell by deferoxamine (Oμmol/L、25μmol/L、100μmol/L、200μmol/L), the function of inhibit proliferation of dihydroartemisinin IC50was decreased along with the increasing concentration of deferoxamine.(6) Cell cloning method found that the function of inhibit Hela cell proliferation of combination of dihydroartemisinin (IC20-IC50) and cisplatin (IC20-IC50) were increased along with the increasing concentration.(7) After test the apoptosis results by flow cytometry,our team found that the early apoptosis rate were:(4.33±2.41,%)、(2.35±0.40,%) and (2.90±0.17,%) by using single and combination of dihydroartemisinin with cisplatin act on the Hela cell6hours later, no significant difference (P>0.05). The early apoptosis rate were:(2.55±0.29,%)、(5.38±0.41,%) and (7.15±0.47,%) by using single and combination of dihydroartemisinin with cisplatin act on the Hela cell24hours later, significant difference (P<0.05). The experiments leads to know:the longer cisplatin and drug combination act, the better function of inducing early apoptosis, it has significant difference between24hours and6hours (P<0.05). The early apoptosis rate of dihydroartemisinin actting on the Hela cell24hours later is lower than6hours,significant difference (P<0.05)Conclusions (1) Dihydroartemisinin have cytotoxic effect, inducing tumor cell apoptosis, so the prospect of application in the clinical treatment of cervical cancer are considerable.(2) Dihydroartemisinin resistance to tumor associated with iron ion within the tumor cells, combines dihydroartemisinin and transferrin, can make the ironion and dihydroartemisinin into tumor cells at the same time, the targeted anti-tumor effect.(3) Dihydroartemisinin can strengthen cisplatin, anti-tumor effect, a joint application in the clinical feasibility of cerical cancer treatment, reduce cisplatin dosage, reduce its side effects.

Related Dissertations

  1. The Effect of RNA Interference-mediated ERCC1 Gene on the Chemo-treatment Sensitivity of NSCLC in Vitro,R734.2
  2. Clinical Observation Pemetrexed Combined with Cisplatin As First-line Treatment of Advanced Lung Adenocarcinoma,R734.2
  3. Influence of NF-κB Inhibitor (PDTC) on Protein Expression of ASPP1 and ASPP2 of Non-small Cell Lung Cancer,R734.2
  4. Influences of Cisplatin on Expressions of P-glycoprotein in the Resistance Cells of in Lung Cancer Xenografts in the Mice,R734.2
  5. Effect of Rh-Endostatin on the Expression of ERCC1 in Human Lung Adenocarcinoma A549 Cells,R734.2
  6. Influence on NF-κB P65 and ASPP2 of Murine Lewis Lung Cancer of NF-кB Inhibitor PDTC and Cisplatin,R734.2
  7. Low- dose cisplatin liver cancer stem cells enriched experimental study,R735.7
  8. NF-κB inhibitor PDTC on non-small cell lung cancer cells and JNK protein expression iASPP impact,R734.2
  9. The Mechanisms of Zoledronic Acid Alone or Combined with Cisplatin on Proliferation of Lung Cancer A549 Cells,R734.2
  10. Association Between Polymorphisms of ERCC1 and XPD and Sensitivity to Platinum-based Chemotherapy in Advanced Non-small Cell Lung Cancer,R734.2
  11. The Expression and Clinical Significance of the Family of Apoptosis Stimulating Protein of P53 in Gastric Cancer,R735.2
  12. Study on the Resistance Mechanism of Carcinoma of Pacreas Induced by TRAIL,R735.9
  13. Establishment of Cisplatin- Resistant Gastric Cancer Cell SGC7901/DDP and the Effect of Recombinant Adenovirus Mediated Human IL-24 Gene to Chemosensitivity,R735.2
  14. Effects of Curcumin on the Gastrointestinal Injury Caused by Cisplatin in Mice,R285.5
  15. Apoptosis Induced by 3-Bromopyruvic Acid on Human Osteosarcoma Cell Line MG63,R738
  16. Interactions between Artemisinin Drugs and Drug-metabolizing Enzyme,R96
  17. A Experimental Study of the Inhibitive Effect and Mehanism of Huangqi Fuzheng Decoction on Lewis Lung Cancer Transplantation Tumor,R734.2
  18. Killing Effect of B-Elemene with Cisplatin and Hyperthermia in Lung Cancer A549 Cells,R734.2
  19. Inhibitation of Xenograft Models Tumour Growth by Herceptin in Patient Derived Esophageal Squamous Carcinoma,R735.1
  20. The Expression of Wrap53 and P53 in Osteosarcoma Cells Treated with Cisplatin,R738.1
  21. Study on Artemisinin Derivatives Pharmacokinetics in Dogs and Metabolism in Vitro,R285.5

CLC: > Medicine, health > Oncology > Genitourinary tumors > Female genital tumors > Uterine tumors
© 2012 www.DissertationTopic.Net  Mobile